TNF alpha inhibitors (Synta)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTNF alpha inhibitors (Synta)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsAutoimmune DiseasesSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMadrigal Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMadrigal Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesSepsis

Other Information

ATC CodeN/A
Related LinksN/A